Page last updated: 2024-08-24

liarozole and 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid

liarozole has been researched along with 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kauffman, FC; Levin, AA; Pignatello, MA1

Other Studies

1 other study(ies) available for liarozole and 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid

ArticleYear
Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures: a model to explain the potency of the aromatic retinoid (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-propenyl] benzoic acid.
    Toxicology and applied pharmacology, 2002, Feb-01, Volume: 178, Issue:3

    Topics: Animals; Antineoplastic Agents; Benzoates; Cells, Cultured; Chondrogenesis; Chromatography, High Pressure Liquid; Drug Synergism; Enzyme Inhibitors; Imidazoles; Limb Buds; Mice; Retinoids; Structure-Activity Relationship; Tretinoin

2002